🧬 New Technology added at Pharmidex in house now: Enhancing Precision in Coagulation Testing🧬
June 9, 2025

We're excited to announce the integration of the Sysmex CA-660 semi-automated Coagulation Analyzer into our lab infrastructure.


This compact yet powerful instrument brings clinical-grade coagulation testing to our preclinical workflows, enabling:


✅ High-precision clotting, chromogenic & immunoassays

✅ Low sample & reagent volume needs ideal for preclinical models

✅ Robust data reproducibility for decision-critical insights

✅ Easy-to-use interface for rapid turnaround


With the CA-660, Pharmidex is further enhancing its capacity to deliver accurate, consistent and fast coagulation studies, a key component in safety pharmacology, clinical pathology and drug development.


This system supports our mission to provide high-quality bioanalytical, DMPK and toxicology services to our partners in biotech and pharma.

Sysmex CA-660 semi-automated Coagulation Analyzer

#Pharmidex #Sysmex #CoagulationTesting #DrugDevelopment #PreclinicalResearch #Bioanalysis #DMPK #LifeSciences #InnovationInBiotech

December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
December 2, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
More Posts